Glucocorticoids were shown to elevate the expression of fibronectin, thus leading to cytoskeleton-dependent YAP activation in human breast cancer.127 Additionally, transforming growth factor-beta (TGF-β) was shown upregulate TAZ levels in mesenchymal and epithelial cells. This evidence concerns the gene YAP1 and breast cancer.